Mallia Therapeutics Alternatives & Competitors
12 companies similar to Mallia Therapeutics — Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD8...
Companies similar to Mallia Therapeutics
Mineralys Therapeutics, Inc.
Public, clinical-stage biopharmaceutical company committed to developing best-in-class, no...
United States
Onconova Therapeutics
Onconova is focused on discovering and developing novel products for patients with cancer.
Newtown, United States
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Track all Mallia Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
SELLAS Life Sciences Group, Inc.
A late-stage clinical biopharmaceutical company focused on developing novel therapies for...
New York, United States
MapLight Therapeutics, Inc.
Creating breakthrough innovative therapeutics for serious CNS disorders
Redwood City, United Stat...
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Xanthus Pharmaceuticals
Innovative treatments for cancer and autoimmune disorders through pioneering small-molecul...
Breye Therapeutics
A Danish-based biopharmaceutical firm in the clinical stages, is working to provide advanc...
Enalare Therapeutics Inc.
Developing novel therapies for life-threatening acute respiratory and critical care condit...
Princeton, United States
Kither Biotech
Improving treatment for patients suffering from incurable respiratory diseases
Turin, Italy
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
About Mallia Therapeutics
Mallia Therapeutics, a biopharmaceutical company headquartered in Germany, is focused on the development of soluble CD83 (sCD83) for the treatment of hair loss. The company, founded in 2023, aims to address the growing demand for innovative solutions in the Biopharma industry. Mallia Therapeutics recently received a si...
Biopharmaceutical, Hair Loss, Treatment, Soluble CD83, SCD83, Novel Treatments
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Mallia Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Mallia Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
